XT
PRAX icon

XTX Topco’s Praxis Precision Medicines PRAX Stock Holding History

XTX Topco’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$433K Buy
+1,344
New +$416K 0.01% 2172
2025
Q2 		– Sell
-10,043
Closed -$380K – 2993
2025
Q1 		$380K Buy
+10,043
New +$627K 0.02% 1226
2023
Q3 		– Sell
-1,209
Closed -$20.9K – 1920
2023
Q2 		$20.9K Buy
+1,209
New +$18.5K ﹤0.01% 1317
2023
Q1 		– Sell
-9,867
Closed -$352K – 1582
2022
Q4 		$352K Buy
9,867
+941
+11% +$29.3K 0.07% 486
2022
Q3 		$304K Buy
8,926
+4,180
+88% +$208K 0.08% 492
2022
Q2 		$174K Buy
+4,746
New +$507K 0.07% 499

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return